DRI Healthcare Trust (DHT.UN) Competitors

C$16.16 -0.15 (-0.92%)

As of 03:59 PM Eastern

DHT.UN vs. BHC, CRON, TLRY, THCX, and GUD

Should you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Bausch Health Companies (BHC), Cronos Group (CRON), Tilray Brands (TLRY), Hydropothecary (THCX), and Knight Therapeutics (GUD). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does DRI Healthcare Trust compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and DRI Healthcare Trust (TSE:DHT.UN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

: 13.5% of Bausch Health Companies shares are held by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: In the previous week, Bausch Health Companies had 1 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 4 mentions for Bausch Health Companies and 3 mentions for DRI Healthcare Trust. DRI Healthcare Trust's average media sentiment score of 0.85 beat Bausch Health Companies' score of 0.22 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
DRI Healthcare Trust
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: DRI Healthcare Trust has a net margin of 5.02% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat DRI Healthcare Trust's return on equity.
Company Net Margins Return on Equity Return on Assets
Bausch Health Companies -13.54% 120.43% 4.16%
DRI Healthcare Trust 5.02% 2.06% 4.22%
: DRI Healthcare Trust has lower revenue, but higher earnings than Bausch Health Companies. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A
DRI Healthcare Trust C$153.37M 5.80 C$9.73M -C$0.91 N/A
: Bausch Health Companies has a beta of 0.588188, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, DRI Healthcare Trust has a beta of 0.347429, suggesting that its stock price is 65% less volatile than the S&P 500.
: DRI Healthcare Trust has a consensus target price of C$18.88, suggesting a potential upside of 16.80%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
DRI Healthcare Trust
0 Sell rating(s)

0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
3.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch Health Companies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
DRI Healthcare Trust	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
DRI Healthcare Trust	5.02%	2.06%	4.22%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A
DRI Healthcare Trust	C$153.37M	5.80	C$9.73M	-C$0.91	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

DRI Healthcare Trust beats Bausch Health Companies on 9 of the 16 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

DRI Healthcare Trust (TSE:DHT.UN) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

: DRI Healthcare Trust presently has a consensus target price of C$18.88, suggesting a potential upside of 16.80%. Cronos Group has a consensus target price of C$4.38, suggesting a potential upside of 21.53%. Given Cronos Group's higher probable upside, analysts plainly believe Cronos Group is more favorable than DRI Healthcare Trust.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
3.00
Cronos Group
0 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
3.00
: In the previous week, DRI Healthcare Trust had 2 more articles in the media than Cronos Group. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 1 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 0.85 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DRI Healthcare Trust
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: DRI Healthcare Trust has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than DRI Healthcare Trust, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DRI Healthcare Trust C$153.37M 5.80 C$9.73M -C$0.91 N/A
Cronos Group C$146.59M 9.24 -C$32.78M -C$0.02 N/A
: DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of -6.37%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.
Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust 5.02% 2.06% 4.22%
Cronos Group -6.37% -0.87% -3.73%
: DRI Healthcare Trust has a beta of 0.347429, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.036621, suggesting that its stock price is 4% more volatile than the S&P 500.
: 0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DRI Healthcare Trust	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cronos Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$153.37M	5.80	C$9.73M	-C$0.91	N/A
Cronos Group	C$146.59M	9.24	-C$32.78M	-C$0.02	N/A

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Cronos Group	-6.37%	-0.87%	-3.73%

Summary

DRI Healthcare Trust beats Cronos Group on 9 of the 15 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Tilray Brands?

DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

: DRI Healthcare Trust presently has a consensus target price of C$18.88, suggesting a potential upside of 16.80%. Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 70.51%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than DRI Healthcare Trust.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: In the previous week, DRI Healthcare Trust and DRI Healthcare Trust both had 3 articles in the media. DRI Healthcare Trust's average media sentiment score of 0.85 beat Tilray Brands' score of 0.36 indicating that DRI Healthcare Trust is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DRI Healthcare Trust
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DRI Healthcare Trust C$153.37M 5.80 C$9.73M -C$0.91 N/A
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A
: DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -158.75%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust 5.02% 2.06% 4.22%
Tilray Brands -158.75% -88.06% -1.41%
: DRI Healthcare Trust has a beta of 0.347429, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.243166, suggesting that its stock price is 224% more volatile than the S&P 500.
: 0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.1% of Tilray Brands shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DRI Healthcare Trust	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tilray Brands	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$153.37M	5.80	C$9.73M	-C$0.91	N/A
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Tilray Brands	-158.75%	-88.06%	-1.41%

Summary

DRI Healthcare Trust beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Hydropothecary?

DRI Healthcare Trust (TSE:DHT.UN) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

: DRI Healthcare Trust has higher revenue and earnings than Hydropothecary.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DRI Healthcare Trust C$153.37M 5.80 C$9.73M -C$0.91 N/A
Hydropothecary N/A N/A N/A N/A N/A
: 0.6% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: In the previous week, DRI Healthcare Trust had 3 more articles in the media than Hydropothecary. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Hydropothecary. DRI Healthcare Trust's average media sentiment score of 0.85 beat Hydropothecary's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.
Company Overall Sentiment
DRI Healthcare Trust Positive
Hydropothecary Neutral
: DRI Healthcare Trust presently has a consensus target price of C$18.88, suggesting a potential upside of 16.80%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, equities analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
3.00
Hydropothecary
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.
Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust 5.02% 2.06% 4.22%
Hydropothecary N/A N/A N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$153.37M	5.80	C$9.73M	-C$0.91	N/A
Hydropothecary	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
DRI Healthcare Trust	Positive
Hydropothecary	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Hydropothecary	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Hydropothecary	N/A	N/A	N/A

Summary

DRI Healthcare Trust beats Hydropothecary on 11 of the 11 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

: DRI Healthcare Trust has lower revenue, but higher earnings than Knight Therapeutics. Knight Therapeutics is trading at a lower price-to-earnings ratio than DRI Healthcare Trust, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Knight Therapeutics C$450.09M 1.64 -C$30.73M -C$0.05 N/A
DRI Healthcare Trust C$153.37M 5.80 C$9.73M -C$0.91 N/A
: 23.5% of Knight Therapeutics shares are owned by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are owned by institutional investors. 45.6% of Knight Therapeutics shares are owned by insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: In the previous week, DRI Healthcare Trust had 3 more articles in the media than Knight Therapeutics. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Knight Therapeutics. DRI Healthcare Trust's average media sentiment score of 0.85 beat Knight Therapeutics' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.
Company Overall Sentiment
Knight Therapeutics Neutral
DRI Healthcare Trust Positive
: Knight Therapeutics currently has a consensus target price of C$6.50, indicating a potential downside of 13.91%. DRI Healthcare Trust has a consensus target price of C$18.88, indicating a potential upside of 16.80%. Given DRI Healthcare Trust's higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Knight Therapeutics.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Knight Therapeutics
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)

0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
3.00
: DRI Healthcare Trust has a net margin of 5.02% compared to Knight Therapeutics' net margin of -1.19%. DRI Healthcare Trust's return on equity of 2.06% beat Knight Therapeutics' return on equity.
Company Net Margins Return on Equity Return on Assets
Knight Therapeutics -1.19% -0.70% 0.51%
DRI Healthcare Trust 5.02% 2.06% 4.22%
: Knight Therapeutics has a beta of -0.214451, suggesting that its share price is 121% less volatile than the S&P 500. Comparatively, DRI Healthcare Trust has a beta of 0.347429, suggesting that its share price is 65% less volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Knight Therapeutics	C$450.09M	1.64	-C$30.73M	-C$0.05	N/A
DRI Healthcare Trust	C$153.37M	5.80	C$9.73M	-C$0.91	N/A

Company	Overall Sentiment
Knight Therapeutics	Neutral
DRI Healthcare Trust	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Knight Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Net Margins	Return on Equity	Return on Assets
Knight Therapeutics	-1.19%	-0.70%	0.51%
DRI Healthcare Trust	5.02%	2.06%	4.22%

Summary

DRI Healthcare Trust beats Knight Therapeutics on 11 of the 15 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DHT.UN vs. The Competition

Export

Metric	DRI Healthcare Trust	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$889.08M	C$1.63B	C$6.25B	C$11.72B
Dividend Yield	3.47%	2.97%	2.73%	6.22%
P/E Ratio	-17.76	4.18	29.04	23.83
Price / Sales	5.80	1,488.53	476.61	13.46
Price / Cash	N/A	10.37	27.62	82.69
Price / Book	1.73	10.72	9.67	4.48
Net Income	C$9.73M	C$21.15B	C$3.55B	C$300.68M
7 Day Performance	-1.52%	-1.18%	1.70%	0.12%
1 Month Performance	-1.76%	0.15%	5.62%	2.88%
1 Year Performance	35.91%	24.15%	34.42%	57.78%

DRI Healthcare Trust Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DHT.UN DRI Healthcare Trust	1.5278 of 5 stars	C$16.16 -0.9%	C$18.88 +16.8%	N/A	C$889.08M	C$153.37M	N/A	N/A	High Trading Volume
BHC Bausch Health Companies	0.5813 of 5 stars	C$7.67 -1.5%	N/A	N/A	C$2.86B	C$10.53B	N/A	19,900	Earnings Report
CRON Cronos Group	1.8087 of 5 stars	C$3.61 -0.3%	C$4.38 +21.2%	N/A	C$1.36B	C$146.59M	N/A	450
TLRY Tilray Brands	1.688 of 5 stars	C$8.38 -1.1%	C$13.30 +58.7%	N/A	C$1.00B	C$858.28M	N/A	2,650
THCX Hydropothecary	N/A	C$5.30 +6.6%	N/A	N/A	C$949.11M	N/A	N/A	N/A	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:DHT.UN) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DRI Healthcare Trust (DHT.UN) Competitors

DHT.UN vs. BHC, CRON, TLRY, THCX, and GUD

How does DRI Healthcare Trust compare to Bausch Health Companies?

Summary

How does DRI Healthcare Trust compare to Cronos Group?

Summary

How does DRI Healthcare Trust compare to Tilray Brands?

Summary

How does DRI Healthcare Trust compare to Hydropothecary?

Summary

How does DRI Healthcare Trust compare to Knight Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DHT.UN vs. The Competition

DRI Healthcare Trust Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DRI Healthcare Trust (DHT.UN) Competitors

DHT.UN vs. BHC, CRON, TLRY, THCX, and GUD

How does DRI Healthcare Trust compare to Bausch Health Companies?

Summary

How does DRI Healthcare Trust compare to Cronos Group?

Summary

How does DRI Healthcare Trust compare to Tilray Brands?

Summary

How does DRI Healthcare Trust compare to Hydropothecary?

Summary

How does DRI Healthcare Trust compare to Knight Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DHT.UN vs. The Competition

DRI Healthcare Trust Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools